Valeant Pharmaceuticals Intl Inc news

   Watch this stock
Showing stories 1 - 10 of about 130   

Articles published

VRX 129.13 +1.11 (0.87%)
price chart
Making Sense of the Valeant Pharmaceuticals International Inc. and Allergan ...
There's a lot of posturing and name-calling going on between Valeant Pharmaceuticals International Inc. (TSX:VRX)(NYSE:VRX) and Allergan, Inc. (NYSE:AGN).
Emails Show Allergan Asked Goldman To �Take off The Gloves� In Valeant Fight  ValueWalk
Bill Ackman Can't Possibly Be Expected To Remember All The Great Ideas ...  DealBreaker
Related articles »  
Why Valeant Pharmaceuticals Intl Inc. and Allergan Inc. Would Be Better Together
Valeant Pharmaceuticals Intl Inc.(TSX: VRX)(NYSE: VRX) and Pershing Square Capital Management LP submitted a hostile bid for Allergan Inc. (NYSE: AGN) months ago, but any potential for a deal appeared dead after both sides exchanged barbs.
Allergan Ups Earnings Guidance Amid Takeover Battle With Valeant  Bidness ETC
Allergan, Inc. Stock Jumps After Big Guidance Increase  ValueWalk
Related articles »  
Actavis plans new merger approach for Allergan Inc as Valeant Pharmaceuticals ...
Allergan, which has repeatedly rejected offers from Valeant Pharmaceuticals International Inc, would consider a takeover proposal that values the company at above $200 per share, some of these people said.
Latest Strategy in Valeant Pharmaceuticals Intl Inc (VRX) -Pershing ...  StockWise Daily
Exclusive: Actavis plans new merger approach for Allergan - sources  Reuters
Related articles »  
Valeant Pharmaceuticals To Announce 2014 Third Quarter Results On October ...
LAVAL, Quebec, Oct. 15, 2014 /CNW/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that it will host a conference call and a live Internet webcast along with a slide presentation on Monday, October 20, 2014 at 8:00 ...
Related articles »  
Stocks in Focus - Valeant Pharmaceuticals Intl Inc (NYSE:VRX), VF Corp (NYSE ...
Valeant Pharmaceuticals Intl Inc (NYSE:VRX) reported mixed financial results for Q3 ended Sept. 30, 2014, with earnings topping analysts' expectations, while revenue came in line, and provided guidance for Q4, fiscal 2014 and fiscal 2015 above Street ...
Valeant Pharmaceuticals Intl Rating Reiterated by Jefferies Group (VRX)
Valeant Pharmaceuticals Intl Inc logo Jefferies Group reaffirmed their buy rating on shares of Valeant Pharmaceuticals Intl (NYSE:VRX) in a report released on Tuesday.
Valeant Pharmaceuticals Intl Receives Average Recommendation of "Buy ...  WKRB News
Valeant Pharmaceuticals Intl Given New $182.00 Price Target at Cantor ...  Watch List News (press release)
Related articles »  
Valeant Pharmaceuticals Intl Inc (VRX) Releases FY15 Earnings Guidance
Valeant Pharmaceuticals Intl logo Valeant Pharmaceuticals Intl Inc (NYSE:VRX) issued an update on its FY15 earnings guidance on Monday morning.
Allergan responds to Bill Ackman's latest claims in hostile Valeant ...  Financial Post
Ackman, Valeant lawyers say Allergan CEO oversaw campaign to discredit ...  euronews
Related articles »  
Buzz Stocks: Microsoft Corporation, Family Dollar Stores, Inc., and Valeant ...
Bolstering the stock is a stronger-than-expected earnings report and forward guidance, and Valeant Pharmaceuticals Intl Inc CEO's confession that the company is just waiting on the "appropriate time" to up its bid for Allergan, Inc. (NYSE:AGN). While ...
Valeant Pharmaceuticals Intl Earns "Buy" Rating from Aegis (VRX)  Ticker Report
Related articles »  
Jeffrey W. Ubben, CEO Of ValueAct Capital, Appointed To The Board Of Valeant ...
25, 2014 /CNW/ -- Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) today announced that its Board of Directors has appointed Jeffrey W. Ubben, Founder, Chief Executive Officer, and the Chief Investment Officer of ValueAct Capital, as a ...
Allergan Issues Statement Regarding Recent Valeant Correspondence  Businessweek
Related articles »  
Valeant Pharmaceuticals Intl Inc (VRX) Issues FY15 Earnings Guidance
Valeant Pharmaceuticals Intl logo Valeant Pharmaceuticals Intl Inc (NYSE:VRX) updated its FY15 earnings guidance on Monday.